Oramed Appoints Ben Shapiro to its Board of Directors

NEW YORK , May 1, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (“Oramed” or the “Company”) ( www.oramed.com ) announced today the appointment of Mr. Benjamin Shapiro to its Board of Directors effective May 1, 2023 . The Board determined that Mr.

Join our mailing list

Skip to content